Phiwath Jittamas/iStock via Getty Images
The following segment was excerpted from Greenhaven Road Capital Main Fund Q1 2025 Investor Letter.
Lifecore Biomedical (LFCR) – As previously discussed, Lifecore is a likely beneficiary of the trade policies. Their largest challenge and opportunity is
#Greenhaven #Road #Capital #Main #Fund #Top #Holdings